Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Lara

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|August 16, 2003
Paroxetine-induced increase in metabolic end products of nitric oxideNathalie Lara, Stephen L Archer, Glen B Baker, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
Paroxetine-induced increase in metabolic end products of nitric oxideNathalie Lara, Stephen L Archer, Glen B Baker, et al.
The Journal of Clinical Psychiatry|January 20, 2004
Increased cholesterol levels during paroxetine administration in healthy menNathalie Lara, Glen B Baker, Stephen L Archer, et al.
Psychoneuroendocrinology|March 26, 2002
Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrinGlendon R Tait, Karen McManus, François Bellavance, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacksNathalie Lara, Wendy E Chrapko, Stephen L Archer, et al.
Biological Psychiatry|July 3, 2004
Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorderWendy E Chrapko, Paul Jurasz, Marek W Radomski, et al.
Journal of Psychiatry & Neuroscience : JPN|April 3, 2003
Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiolJarret D Morrow, Karen McManus, Glendon R Tait, et al.
Psychopharmacology|April 24, 2007
Delayed increase in LDL cholesterol following pentagastrin-induced panic attacksJorge Perez-Parada, Gian S Jhangri, Nathalie Lara, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patientsWendy Chrapko, Paul Jurasz, Marek W Radomski, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiolJean Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|August 16, 2003
Paroxetine-induced increase in metabolic end products of nitric oxideNathalie Lara, Stephen L Archer, Glen B Baker, et al.
Journal of Clinical Psychopharmacology|November 19, 2003
Paroxetine-induced increase in metabolic end products of nitric oxideNathalie Lara, Stephen L Archer, Glen B Baker, et al.
The Journal of Clinical Psychiatry|January 20, 2004
Increased cholesterol levels during paroxetine administration in healthy menNathalie Lara, Glen B Baker, Stephen L Archer, et al.
Psychoneuroendocrinology|March 26, 2002
Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrinGlendon R Tait, Karen McManus, François Bellavance, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacksNathalie Lara, Wendy E Chrapko, Stephen L Archer, et al.
Biological Psychiatry|July 3, 2004
Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorderWendy E Chrapko, Paul Jurasz, Marek W Radomski, et al.
Journal of Psychiatry & Neuroscience : JPN|April 3, 2003
Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiolJarret D Morrow, Karen McManus, Glendon R Tait, et al.
Psychopharmacology|April 24, 2007
Delayed increase in LDL cholesterol following pentagastrin-induced panic attacksJorge Perez-Parada, Gian S Jhangri, Nathalie Lara, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patientsWendy Chrapko, Paul Jurasz, Marek W Radomski, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiolJean Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, et al.
Pageof 1